Our application* to get co-packaged ORS and zinc on the WHO Essential Medicines List has been successful. This is game-changer. It moves ColaLife’s work out of the ‘innovation box’ into the mainstream of global children’s public health – with better designed, easier-to-dispense diarrhoea treatment available for sick children – potentially everywhere. A summary of the […]
Application submitted to WHO to add co-packaged ORS and zinc to the WHO Essential Medicines List
12 November 2018 by
Today (12-Nov-18) was a very big day for ColaLife. It was on 28-Jan-17, when the penny dropped for me. Why isn’t co-packaged ORS and Zinc on WHO’s Essential Medicines List for Children (EMLc)? ORS is listed and zinc is listed and this has been the case for nearly 15 years but still only about 7% of […]
Making the Case for Inclusion of Co-packaged ORS/Zinc on the WHO Model List of Essential Medicines for Children (EMLc)
27 March 2017 by
The WHO Model List of Essential Medicines For four decades, the World Health Organisation (WHO) has devoted substantial effort to an essential medicines programme that seeks to improve access to the most needed drugs and devices. The meeting of the 21st WHO Expert Committee on the Selection and Use of Essential Medicines will be held […]
Rohit Ramchandani’s DrPH thesis published online
12 November 2016 by
We are very pleased to announce that Rohit Ramchandani’s DrPH thesis (Jan-16) has finally been published on the Johns Hopkins Sheridan Libraries website. It’s entitled: EMULATING COMMERCIAL, PRIVATE-SECTOR VALUE-CHAINS TO IMPROVE ACCESS TO ORS AND ZINC IN RURAL ZAMBIA: EVALUATION OF THE COLALIFE TRIAL. The abstract can be read directly from the website here (and […]
COTZ Final Report available
28 July 2014 by
This is the final report of the COTZ Project and was produced by the ColaLife team: Jane Berry, Simon Berry and Rohit Ramchandani. It covers all aspects of the trial: the trial objectives; project need and policy context; the voucher system; sales; costing and pricing; sustainability and forward plans; and finances and cost effectiveness. It […]
Endline Survey Report published
22 July 2014 by
During the ColaLife Operational Trial Zambia (COTZ) three sets of surveys were carried out: a baseline; midline (after 6 months) and endline. All surveys included a household survey and a survey of retailers. The midline and endline also looked at the impact we were having on the rural health centres in the trial sites. Technical […]
Gates Foundation and Microsoft to screen the ColaLife documentary – 20 and 21-May in Seattle
8 May 2014 by
In April Inc.com listed The Cola Road as one of 5 Documentaries About Entrepreneurs You Need to Watch This Spring. This month, in Seattle, there will be two opportunities to see the award-winning, independently made ColaLife documentary – The Cola Road . Each free showing will be followed by a Q&A with the filmmaker, Claire Ward, ColaLife co-founder, Simon Berry […]
Kit Yamoyo presented at UN General Assembly as breakthrough innovation
23 September 2013 by
Our strategy for impact is that others pick up what we are learning from the trial in Zambia and incorporate this into their own programmes. For this strategy to work people need to know what we are doing and we need endorsement from reputable sources. For this reason we are very pleased to be showcased […]
Kit Yamoyo sales fall as vouchers are withdrawn
26 June 2013 by
Our aim in the COTZ trial has always been to test private sector market-based approaches to distributing a new anti-diarrhoea kit (Kit Yamoyo). That was the model that our Zambian partners proposed and preferred – including the Ministry of Health. They wanted a ‘trade-not-aid’ model – and we agreed – although we have been able […]
ColaLife wins the top prize at the DuPont Packaging Innovation Awards
17 May 2013 by
Last night (16/5/13) while we slept in Zambia, there were celebrations going in Wilmington, Delaware, USA at the DuPont Packaging Innovation Awards. This morning we learnt that we’d won the top prize (Diamond) and we also won in the ‘Food Security’ category. It was great that our colleague, Rohit Ramchandani, was there and met up […]
